Position in OMER
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$24,718,118
-$13,472,712 QoQ
Shares Held
2,340,731
+5.3% QoQ
Ownership
3.23%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 85.41784596350456.ToString("F0")%
Shared 0.ToString("F0")%
None 14.582154036495437.ToString("F0")%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. OMER ranks #61 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in OMER
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,718,118 | 2,340,731 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $38,190,830 | 2,222,982 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,907,264 | 709,089 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,605,500 | 868,500 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,430,600 | 660,657 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,389,966 | 849,187 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,786,792 | 450,074 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,957,467 | 482,135 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,858,451 | 538,682 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,617,164 | 494,546 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,724,674 | 590,642 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $3,163,207 | 581,472 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,431,358 | 522,873 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,477,262 | 653,656 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $2,056,140 | 652,743 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,855,645 | 674,780 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,272,565 | 544,520 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,496,421 | 543,767 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,223,381 | 523,813 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,239,485 | 487,836 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,537,289 | 479,623 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $8,867,372 | 620,530 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,419,202 | 536,024 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,111,039 | 483,087 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $6,727,783 | 503,200 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||